StockData
PROCEPT BioRobotics Corp logo

PROCEPT BioRobotics Corp (PRCT) stock

PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3050% below fair value
$23.78+0.24 (+1.02%)

Close on Nov 17, 2026Market cap $1.36BP/E –Yield –

PROCEPT BioRobotics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

PROCEPT BioRobotics's operating cash flow for the twelve months ending Jun 30, 2026 was -$74.34M. For fiscal 2025 it was -$48.99M. The highest annual figure on record is -$48.34M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$48.99M–
FY2024Dec 31, 2024-$99.21M–
FY2023Dec 31, 2023-$108.00M–
FY2022Dec 31, 2022-$80.38M–
FY2021Dec 31, 2021-$57.33M–
FY2020Dec 31, 2020-$48.34M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$19.25M–
Q1 FY2026Mar 31, 2026-$38.13M–
Q4 FY2025Dec 31, 2025-$10.33M–
Q3 FY2025Sep 30, 2025-$6.64M–
Q2 FY2025Jun 30, 2025-$15.04M–
Q1 FY2025Mar 31, 2025-$16.98M–
Q4 FY2024Dec 31, 2024-$32.39M–
Q3 FY2024Sep 30, 2024-$18.80M–
Q2 FY2024Jun 30, 2024-$15.74M–
Q1 FY2024Mar 31, 2024-$32.29M–
Q4 FY2023Dec 31, 2023-$24.79M–
Q3 FY2023Sep 30, 2023-$18.94M–
Q2 FY2023Jun 30, 2023-$28.34M–
Q1 FY2023Mar 31, 2023-$35.93M–
Q4 FY2022Dec 31, 2022-$25.17M–
Q3 FY2022Sep 30, 2022-$19.85M–
Q2 FY2022Jun 30, 2022-$17.13M–
Q1 FY2022Mar 31, 2022-$18.23M–
Q4 FY2021Dec 31, 2021-$16.48M–
Q3 FY2021Sep 30, 2021-$12.75M–
Q2 FY2021Jun 30, 2021-$12.91M–
Q1 FY2021Mar 31, 2021-$15.20M–
Q4 FY2020Dec 31, 2020-$13.45M–

More PROCEPT BioRobotics figures

See a number that looks wrong?